Transgenic mice overexpressing renin exhibit glucose intolerance and diet-genotype interactions

Frontiers in Endocrinology

Volumn 3, Issue JAN, 2013, Pages

  Fletcher, Sarah J ^a   Kalupahana, Nishan S ^b   Soltani Bejnood, Morvarid ^c   Kim, Jung Han ^d   Saxton, Arnold M ^a   Wasserman, David H ^e   De Taeye, Bart ^e   Voy, Brynn H ^a   Quignard Boulange, Annie ^f   Moustaid Moussa, Naima ^a,g  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF PERADENIYA   (Sri Lanka)

^c Pellissippi State Community College   (United States)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AGROPARISTECH   (France)

^g TEXAS TECH UNIVERSITY   (United States)

Author keywords

Adipose tissue; Angiotensin II.; Insulin resistance; Renin angiotensin system

Indexed keywords

EID: 84874257084     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00166     Document Type: Article

References (38)

1. Achard,V.,Boullu-Ciocca, S.,Desbriere, R., Nguyen, G., and Grino, M. (2007). Renin receptor expression in human adipose tissue. Am. J. Physiol Regul Integr. Comp. Physiol. 292, R274-R282.
2. Ayala, J. E., Bracy, D. P., McGuin-ness, O. P., and Wasserman, D. H. (2006). Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390-397.
3. Bosch, J., Yusuf, S., Gerstein, H. C., Pogue, J., Sheridan, P., Dagenais, G., et al. (2006). Effect of ramipril on the incidence of diabetes. N. Engl. J. Med. 355,1551-1562.
4. Brink, M., Wellen, J., and Delafontaine, P. (1996). Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 97, 2509-2516.
5. Caron, K. M., James, L. R., Kim, H. S., Knowles, J., Uhlir, R., Mao, L.,et al. (2004). Cardiac hypertrophy and sudden death in mice with a genetically clamped renin transgene. Proc. Natl. Acad. Sci. U.S.A. 101, 3106-3111.
6. Caron, K. M., James, L. R., Kim, H. S., Morham, S. G., Sequeira Lopez, M. L., Gomez, R. A., et al. (2002). A genetically clamped renin transgene for the induction of hypertension. Proc. Natl. Acad. Sci. U.S.A. 99, 8248-8252.
7. Cassis, L. A. (2000). Fat cell metabolism: insulin, fatty acids, andrenin. Curr. Hypertens. Rep. 2, 132-138.
8. Cassis, L. A., Marshall, D. E., Fettinger, M. J., Rosenbluth, B., and Lodder, R. A. (1998). Mechanisms contributing to angiotensin II regulation of body weight. Am. J. Physiol. 274(Pt 1), E867-E876.
9. Duckworth,W. C., Bennett,R. G., and Hamel, F. G. (1998). Insulin degradation: progress and potential. Endocr. Rev. 19, 608-624.
10. Goodarzi, M. O., Taylor, K. D., Guo, X., Quinones, M. J., Cui, J., Li, X.,et al. (2005). Variation in the gene for muscle-specific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 54, 1222-1227.
11. Griffin, S. A., Brown, W. C., MacPher-son, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., et al. (1991). Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17, 626-635.
12. Hatada, S., Kuziel, W., Smithies, O., and Maeda, N. (1999). The influence of chromosomal location on the expression of two transgenes in mice. J. Biol Chem. 274, 948-955.
13. Jayasooriya, A. P., Mathai, M. L., Walker, L. L., Begg, D. P., Denton, D. A., Cameron-Smith, D., et al. (2008). Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc. Natl. Acad. Sci. U.S.A. 105,6531-6536.
14. Jeunemaitre, X. (2008). Genetics of the human renin angiotensin system. J Mol. Med. (Berl.) 86, 637-641.
15. Jeunemaitre, X., Gimenez-Roqueplo, A. P., Celerier, J., and Corvol, P. (1999). Angiotensinogen variants and human hypertension. Curr. Hypertens. Rep. 1, 31-41.
16. Jones, B. H., Standridge, M. K., and Moustaid, N. (1997). Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138,1512-1519.
17. Kalupahana, N. S., Massiera, F., Quignard-Boulange, A., Ailhaud, G., Voy, B. H., Wasserman, D. H., et al. (2012). Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring) 20,48-56.
18. Kalupahana, N. S., and Moustaid-Moussa, N. (2012a). The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes. Rev. 13, 136-149.
19. Kalupahana, Nishan S., and Moustaid-Moussa, N. (2012b). The adiposetissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit. Rev. Biochem. Mol. Biol. 47, 379-390.
20. Kim, S., and Moustaid-Moussa, N. (2000). Secretory, endocrine and autocrine/paracrine function of the adipocyte. J. Nutr. 130, 3110S-3115S.
21. Langheinrich, M., Lee, M. A., Bohm, M., Pinto, Y. M., Ganten, D., and Paul, M. (1996). The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects. Am. J. Hypertens. 9, 506-512.
22. Lee, M. A., Bohm, M., Paul, M., Bader, M., Ganten, U., and Ganten, D. (1996). Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am. J. Physiol. 270(Pt 1),E919-E929.
23. Lee, M. H., Song, H. K., Ko, G. J., Kang, Y. S., Han, S. Y., Han, K. H., et al. (2008). Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int. 74, 890-900.
24. Massiera, F., Bloch-Faure, M., Ceiler, D., Murakami, K., Fukamizu, A., Gasc, J. M., et al. (2001a). Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 15, 2727-2729.
25. Massiera, F., Seydoux, J., Geloen, A., Quignard-Boulange, A., Turban, S., Saint-Marc, P., et al. (2001b). Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142, 5220-5225.
26. Mullins, J. J., Peters, J., and Ganten, D. (1990). Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344, 541-544.
27. Najjar, S. M. (2002). Regulation of insulin action by CEACAM1. Trends Endocrinol. Metab. 13, 240-245.
28. Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sakoda, H., Anai, M., et al. (2002). Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40,872-879.
29. Ran, J., Hirano, T., and Adachi, M. (2004). Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats. Am. J. Physiol. Endocrinol. Metab. 287, E955-E961.
30. Schmieder, R. E., Hilgers, K. F., Schlaich, M. P., and Schmidt, B. M. (2007). Renin-angiotensin system and cardiovascular risk. Lancet 369,1208-1219.
31. Schorr, U., Blaschke, K., Turan, S., Distler, A., and Sharma, A. M. (1998). Relationship between angiotensinogen, leptin and blood pressure levels in young nor-motensive men. J. Hypertens. 16, 1475-1480.
32. Shanik, M. H., Xu, Y., Skrha, J., Dankner, R., Zick, Y., and Roth, J. (2008). Insulin resistance and hyperinsu-linemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31(Suppl. 2),S262-S268.
33. Takahashi, N., Li, F., Hua, K., Deng, J., Wang, C. H., Bowers, R. R., et al. (2007). Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 6, 506-512.
34. Truett, G. E., Heeger, P., Mynatt, R. L., Truett, A. A., Walker, J. A., and War-man, M. L. (2000). Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29, 52, 54.
35. Van Harmelen, V., Ariapart, P., Hoffst-edt, J., Lundkvist, I., Bringman, S., and Arner, P. (2000). Increased adipose angiotensinogen gene expression in human obesity. Obes. Res. 8, 337-341.
36. Vermes, E., Ducharme, A., Bourassa, M. G., Lessard, M., White, M., and Tardif,J. C. (2003). Enalapril reduces the incidence of diabetes in patientswith chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 107, 1291-1296.
37. Xiao, F., Wei, H., Song, S., Li, G., and Song, C. (2006). Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. J. Gastroenterol. Hepatol.21, 1488-1491.
38. Yvan-Charvet, L., Even, P., Bloch-Faure, M., Guerre-Millo, M., Moustaid-Moussa, N., Ferre, P., et al. (2005). Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54,991-999.